Monoclonal versus polyclonal ELISA for assessment of fecal elastase concentration: pitfalls of a new assay.

BSJFW, et al. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous hemochromatosis. Gut 2000;46:405–9. 14. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139–200. 15. Adams PC, Bhayana V. Unsaturated iron binding capacity: a screening test for hemochromatosis? Clin Chem 2000;46:1870–1. 16. McLaren C, Barton J, Adams P, Harris E, Acton R, Press N, et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325: 53–62. 17. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening of a racially diverse population. N Engl J Med 2005;352:1769–78. 18. DeLong E, DeLong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 1988;44:837–44. 19. Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993;30:521–39. 20. Obuchowski N, Lieber M, Wians F. ROC curves in clinical chemistry: Uses, misuses, and possible solutions. Clin Chem 2004;50:1118–25. 21. Zweig M, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561– 77. 22. Pietrangelo A. Non-HFE hemochromatosis. Hepatology 2004;39:21–9. 23. Guillygomarch A, Jacquelinet C, Moirand R, Vincent Q, David V, Deugnier Y. Circadian variations of transferrin saturation levels in iron-overloaded patients: implications for screening of C282Y-linked haemochromatosis. Br J Haematol 2003;120:359–63.